NaoTrac, the CE-certified neurosurgical navigation robot, achieved approval 
from the local government of the Ministry of Health and Welfare in Taiwan in 
July 2022 and is planned for submission to the FDA (U.S. Food and Drug 
Administration) for clearance by the end of 2022.

The NaoTrac human trials were performed at the reputable Hualien Tzu-Chi 
Medical Center, with the External Ventricular Drain (EVD) placement abstract 
results published in the well-known European journal Acta Neurochirurgica. Dr. 
Tsung-Lang, Chiu stated, "The results of this report show that the average time 
spent on the patient registration was 1423.8 seconds. The mean target deviation 
was 1.68mm, and the mean angular deviation was 1.99 degrees, all within the 
accepted tolerance for minimal tissue damage." Dr. Chiu concluded, "NaoTrac has 
several advantages besides the high precision, like a non-invasive, non-contact 
patient registration process with a fast and accurate procedure, the system 
provides precise navigation to the surgical target. It's also user-friendly, 
and has many other benefits."

NaoTrac's technology, Surface Mapping Auto-Registration Technology (SMART), 
merges machine vision, robotics, and A.I. to streamline surgical procedures 
with real-time imaging and minimal invasive outcomes. NaoTrac will be used for 
other surgeries like endoscopic brain surgery, cell implantation, and other 
operations. Brain Navi is attending the CNS Annual Meeting held in San 
Francisco, and the Taiwan Expo USA 2022 in Washington D.C., both in October, to 
showcase NaoTrac and the release of the neurosurgical endoscope.

About Brain Navi

Brain Navi Biotechnology is a leading Taiwanese surgical robotic company. We 
design and develop innovative navigation and robotic surgery technologies for 
surgeons to improve surgical accuracy. Brain Navi's exclusive Surface Mapping 
Auto-registration Technology (SMART) is a significant surgical robotic 
breakthrough that merges machine vision, robotics, and AI technology to achieve 
streamlined surgical procedures with real-time imaging and minimal invasive 
outcomes.

Source Brain Navi Biotechnology Co., Ltd.

Image Attachments Links:

   Link: https://iop.asianetnews.net/view-attachment?attach-id=427098

   Caption: Taiwan approves the First Autonomous Neurosurgical Navigation 
Robot, NaoTrac, from Brain Navi Biotechnology